Pinnbrook Capital Management LP Purchases Shares of 49,900 Bruker Corporation $BRKR

Pinnbrook Capital Management LP purchased a new position in shares of Bruker Corporation (NASDAQ:BRKR) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 49,900 shares of the medical research company’s stock, valued at approximately $3,003,000.

A number of other large investors also recently modified their holdings of BRKR. Thrivent Financial for Lutherans increased its position in Bruker by 561.3% during the 4th quarter. Thrivent Financial for Lutherans now owns 179,792 shares of the medical research company’s stock worth $8,470,000 after purchasing an additional 152,603 shares in the last quarter. Hantz Financial Services Inc. lifted its position in Bruker by 202.7% during the fourth quarter. Hantz Financial Services Inc. now owns 41,306 shares of the medical research company’s stock valued at $1,946,000 after buying an additional 27,659 shares in the last quarter. Franklin Resources Inc. lifted its position in Bruker by 317.7% during the fourth quarter. Franklin Resources Inc. now owns 2,309,404 shares of the medical research company’s stock valued at $108,796,000 after buying an additional 1,756,460 shares in the last quarter. Fifth Third Bancorp grew its stake in Bruker by 4,058.3% during the first quarter. Fifth Third Bancorp now owns 57,135 shares of the medical research company’s stock worth $2,064,000 after buying an additional 55,761 shares during the period. Finally, Amundi grew its stake in Bruker by 244.2% during the first quarter. Amundi now owns 62,611 shares of the medical research company’s stock worth $2,261,000 after buying an additional 44,421 shares during the period. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on BRKR. Weiss Ratings upgraded shares of Bruker from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 3rd. Wall Street Zen upgraded Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. UBS Group set a $60.00 price objective on Bruker in a research report on Wednesday, June 24th. Zacks Research upgraded Bruker from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 4th. Finally, Stifel Nicolaus set a $50.00 target price on Bruker in a report on Wednesday, August 5th. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $56.64.

Bruker Stock Performance

Shares of BRKR stock opened at $59.56 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.85 and a quick ratio of 0.92. The company’s fifty day moving average price is $58.66 and its two-hundred day moving average price is $47.48. The firm has a market capitalization of $9.07 billion, a P/E ratio of -85.09, a P/E/G ratio of 1.82 and a beta of 1.28. Bruker Corporation has a 12 month low of $28.53 and a 12 month high of $65.30.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.11. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The business had revenue of $838.50 million for the quarter, compared to analyst estimates of $853.57 million. During the same period in the previous year, the company earned $0.32 earnings per share. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, research analysts anticipate that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be issued a $0.05 dividend. The ex-dividend date of this dividend is Monday, September 21st. This represents a $0.20 annualized dividend and a yield of 0.3%. Bruker’s dividend payout ratio is currently -28.57%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.